These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17971678)

  • 21. Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia.
    Malfuson JV; Etienne A; Turlure P; de Revel T; Thomas X; Contentin N; Terré C; Rigaudeau S; Bordessoule D; Vey N; Gardin C; Dombret H;
    Haematologica; 2008 Dec; 93(12):1806-13. PubMed ID: 18838471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are bisphosphonates the suitable anticancer drugs for the elderly?
    Santini D; Fratto ME; Galluzzo S; Vincenzi B; Tonini G
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):83-94. PubMed ID: 18692400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The difficult trials.
    Herrstedt J
    Onkologie; 2009 Feb; 32(1-2):7-8. PubMed ID: 19209012
    [No Abstract]   [Full Text] [Related]  

  • 24. Treating the elderly badly.
    Hobson K
    US News World Rep; 2003 Aug; 135(4):49. PubMed ID: 12931481
    [No Abstract]   [Full Text] [Related]  

  • 25. Incorporating novel treatment strategies into conventional therapy.
    Estey EH
    Clin Adv Hematol Oncol; 2009 Jun; 7(6):4-7. PubMed ID: 19645129
    [No Abstract]   [Full Text] [Related]  

  • 26. Too few older patients in cancer trials: experts say disparity affects research results and care.
    Mitka M
    JAMA; 2003 Jul; 290(1):27-8. PubMed ID: 12837701
    [No Abstract]   [Full Text] [Related]  

  • 27. Patient selection for a curative approach to carcinomatosis.
    Piso P; Glockzin G; von Breitenbuch P; Sulaiman T; Popp F; Dahlke M; Esquivel J; Schlitt HJ
    Cancer J; 2009; 15(3):236-42. PubMed ID: 19556910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rebuttal from authors re: Joaquim Bellmunt. Chemotherapy for prostate cancer in senior adults: are we treating the elderly or the frail? Eur Urol 2009;55:1310-2.
    Italiano A; Fizazi K
    Eur Urol; 2009 Jun; 55(6):1313-4. PubMed ID: 18849106
    [No Abstract]   [Full Text] [Related]  

  • 29. Advancing the cause for clinical trials with the elderly.
    Provider; 2004 Feb; 30(2):30-1, 33. PubMed ID: 14964918
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemotherapy options and outcomes in older adult patients with colorectal cancer.
    Saif MW; Lichtman SM
    Crit Rev Oncol Hematol; 2009 Nov; 72(2):155-69. PubMed ID: 19356946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology of antineoplastic medications in older cancer patients.
    Balducci L
    Oncology (Williston Park); 2009 Jan; 23(1):78-85. PubMed ID: 19283925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ethics of phase 0 oncology trials.
    Abdoler E; Taylor H; Wendler D
    Clin Cancer Res; 2008 Jun; 14(12):3692-7. PubMed ID: 18559585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should patient-reported outcomes be mandatory for toxicity reporting in cancer clinical trials?
    Bruner DW
    J Clin Oncol; 2007 Dec; 25(34):5345-7. PubMed ID: 18048812
    [No Abstract]   [Full Text] [Related]  

  • 34. Trend toward noninferiority trials may mean more difficult interpretation of trial results.
    Tuma RS
    J Natl Cancer Inst; 2007 Dec; 99(23):1746-8. PubMed ID: 18042926
    [No Abstract]   [Full Text] [Related]  

  • 35. The challenges of clinical trials for adolescents and young adults with cancer.
    Ferrari A; Montello M; Budd T; Bleyer A
    Pediatr Blood Cancer; 2008 May; 50(5 Suppl):1101-4. PubMed ID: 18360838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment for recurrent uterine cancer].
    Sagae S; Sugimura M; Nagata M
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):220-3. PubMed ID: 19263610
    [No Abstract]   [Full Text] [Related]  

  • 37. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.
    Suman VJ; Dueck A; Sargent DJ
    Cancer Invest; 2008 Jun; 26(5):439-44. PubMed ID: 18568764
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk-adapted use of intravesical immunotherapy.
    Braasch MR; Böhle A; O'Donnell MA
    BJU Int; 2008 Nov; 102(9 Pt B):1254-64. PubMed ID: 19035890
    [No Abstract]   [Full Text] [Related]  

  • 40. Response assessment in clinical trials: implications for sarcoma clinical trial design.
    Jaffe CC
    Oncologist; 2008; 13 Suppl 2():14-8. PubMed ID: 18434633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.